Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC

Stock Information for Diffusion Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.